North American Symptomatic Carotid Endarterectomy Trial [NASCET] and European Carotid Surgery Trial) studied plaque removal with carotid endarterectomy versus best medical management for the treatment of patients with ipsilateral carotid artery stenosis (European Carotid Surgery Trialists' Collaborators Group, 1991; NASCET Collaborators, 1991).
What does NASCET stand for?
NASCET stands for North American Symptomatic Carotid Endarterectomy Trial
This definition appears very frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
- Organizations, NGOs, schools, universities, etc.
- National Air Survey Center Corp.
- National Association of Service & Conservation Corps
- Naval Air Station Corpus Christi
- North American Sports Car Championship
- North American Steel Construction Conference
- Northern Alberta Sports Car Club (Edmonton, Alberta, Canada)
- National Association of State Catholic Conference Directors
- National Association for Sick Child Daycare (Birmingham, AL)
- National Association for Sickle Cell Disease (now Sickle Cell Disease Association of America, Inc.)
- National Association of State Coordinators for the Education of Homeless Children and Youth (Minneapolis, MN)
- National Association of State Comprehensive Health Insurance Plans
- North American Society for Cardiac Imaging (Raleigh, NC)
- National Association of Small and Cottage Industries of Bangladesh
- North American Spinal Cord Injury Conference and Disability Expo
- Not A Snowball's Chance in Hell
- National Association of State Chief Information Officers
- National Acute Spinal Cord Injury Study
- National Association of State Contractors' Licensing Agencies
- National Academy of Science Committee On Oceanography
- National Account Service Company LLC
Samples in periodicals archive:
In landmark trials done at expert institutions by expert operators, such as the North American Symptomatic Carotid Endarterectomy Trial (NASCET), the risk of stroke and death at 30 days in patients with contralateral carotid occlusion was 14%--well above the 6% limit for symptomatic patients as set by an American Heart Association consensus panel.
North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators.
 Endarterectomy for less than 30% stenosis remains of unproven value and awaits analysis of the patients in North American Symptomatic Carotid Endarterectomy Trial (NASCET) who on central review had degrees of stenosis less than 30%.